383 related articles for article (PubMed ID: 29937406)
1. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
2. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
3. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
[TBL] [Abstract][Full Text] [Related]
5. The importance of viral and cellular factors on flavivirus entry.
Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein.
Sharma N; Prosser O; Kumar P; Tuplin A; Giri R
Antiviral Res; 2020 Oct; 182():104876. PubMed ID: 32783901
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to flavivirus drug discovery.
Botting C; Kuhn RJ
Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
[TBL] [Abstract][Full Text] [Related]
8. Identification of small molecule inhibitors targeting the Zika virus envelope protein.
Pitts J; Hsia CY; Lian W; Wang J; Pfeil MP; Kwiatkowski N; Li Z; Jang J; Gray NS; Yang PL
Antiviral Res; 2019 Apr; 164():147-153. PubMed ID: 30771406
[TBL] [Abstract][Full Text] [Related]
9. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
[TBL] [Abstract][Full Text] [Related]
10. Closing the door on flaviviruses: entry as a target for antiviral drug design.
Perera R; Khaliq M; Kuhn RJ
Antiviral Res; 2008 Oct; 80(1):11-22. PubMed ID: 18585795
[TBL] [Abstract][Full Text] [Related]
11. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.
Telehany SM; Humby MS; McGee TD; Riley SP; Jacobs A; Rizzo RC
Biochemistry; 2020 Oct; 59(39):3709-3724. PubMed ID: 32876433
[TBL] [Abstract][Full Text] [Related]
12. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI
Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.
Liu HY; Li Z; Reindl T; He Z; Qiu X; Golden RP; Donovan KA; Bailey A; Fischer ES; Zhang T; Gray NS; Yang PL
Nat Commun; 2024 Jun; 15(1):5179. PubMed ID: 38898037
[TBL] [Abstract][Full Text] [Related]
14. Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening.
Dai S; Zhang Y; Zhang T; Zhang B; Wang H; Deng F
Viruses; 2018 Jul; 10(7):. PubMed ID: 29997331
[TBL] [Abstract][Full Text] [Related]
15. A small molecule fusion inhibitor of dengue virus.
Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
[TBL] [Abstract][Full Text] [Related]
16. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
[TBL] [Abstract][Full Text] [Related]
17. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.
Boldescu V; Behnam MAM; Vasilakis N; Klein CD
Nat Rev Drug Discov; 2017 Aug; 16(8):565-586. PubMed ID: 28473729
[TBL] [Abstract][Full Text] [Related]
18. Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses.
Haviernik J; Štefánik M; Fojtíková M; Kali S; Tordo N; Rudolf I; Hubálek Z; Eyer L; Ruzek D
Viruses; 2018 Apr; 10(4):. PubMed ID: 29642580
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of flavivirus membrane fusion.
Stiasny K; Fritz R; Pangerl K; Heinz FX
Amino Acids; 2011 Nov; 41(5):1159-63. PubMed ID: 19882217
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]